Introduction The Aromatase Deficiency Market is emerging as a specialized yet increasingly significant segment within the broader rare diseases and endocrine disorders landscape. Aromatase deficiency is a rare genetic condition caused by mutations in the CYP19A1 gene, leading to impaired estrogen synthesis. This condition affects both males and females, resulting in abnormal sexual development,...